Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause

During the menopausal transition, women experience a number of symptoms due to declining estrogen levels, including vasomotor symptoms and vulvar and vaginal atrophy (VVA). Unlike vasomotor symptoms, vaginal dryness and dyspareunia, the main symptoms of VVA, typically worsen without treatment and ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurz, Gregory T, Kao, Chiao-Jung, DeGregorio, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235480/
https://www.ncbi.nlm.nih.gov/pubmed/25419123
http://dx.doi.org/10.2147/CIA.S73753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235480/
https://www.ncbi.nlm.nih.gov/pubmed/25419123
http://dx.doi.org/10.2147/CIA.S73753

Ejemplares similares